World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
17904
World Ranking
6993
National Ranking
468

Overview

Toshiyuki Sakai is affiliated with Kyoto Prefectural University of Medicine in Japan. Their research spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on subfields such as Molecular Biology, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, and Cancer Research.

The main topics of Toshiyuki Sakai's work include:

  • Cancer Mechanisms and Therapy
  • Lung Cancer Treatments and Mutations
  • Phagocytosis and Immune Regulation
  • Cancer, Hypoxia, and Metabolism
  • Histone Deacetylase Inhibitors Research
  • PI3K/AKT/mTOR signaling in cancer
  • Melanoma and MAPK Pathways

Frequent co-authors collaborating with Toshiyuki Sakai are:

  • Mano Horinaka
  • Tadaaki Yamada
  • Koichi Takayama
  • Yuki Katayama
  • Michihiro Mutoh

Their publications often appear in journals such as:

  • Cancers
  • Cancer Letters
  • Cancer Science
  • Molecular Cancer Therapeutics
  • Annals of Oncology

Recent notable papers authored or co-authored by Toshiyuki Sakai include:

  • "ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR -Mutated Non-Small Cell Lung Cancer", 2020, Clinical Cancer Research
  • "Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial", 2021, The Lancet. Gastroenterology & hepatology
  • "xCT Inhibition Increases Sensitivity to Vorinostat in a ROS-Dependent Manner", 2020, Cancers
  • "Citrus limon L.-Derived Nanovesicles Show an Inhibitory Effect on Cell Growth in p53-Inactivated Colorectal Cancer Cells via the Macropinocytosis Pathway", 2022, Biomedicines
  • "Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells", 2021, Biochemical and Biophysical Research Communications

Best Publications

  • Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.

    T Sakai;J Toguchida;N Ohtani;D W Yandell

  • Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals.

    Tiina Matikainen;Gloria I. Perez;Andrea Jurisicova;Andrea Jurisicova;James K. Pru

  • Thioredoxin-dependent Redox Regulation of p53-mediated p21 Activation

    Masaya Ueno;Hiroshi Masutani;Roberto Jun Arai;Akira Yamauchi

  • Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line

    Katsunori Nakano;Takakazu Mizuno;Yoshihiro Sowa;Tetsuro Orita

  • Genistein arrests cell cycle progression at G2-M.

    Yoshizumi Matsukawa;Nobuyuki Marui;Toshiyuki Sakai;Yoshiko Satomi

  • CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene

    N. Ohtani-Fujita;T. Fujita;A. Aoike;N. E. Osifchin

  • The effect of quercetin on cell cycle progression and growth of human gastric cancer cells.

    Mitsumori Yoshida;Toshiyuki Sakai;Nobuko Hosokawa;Nobuyuki Marui

  • Histone Deacetylase Inhibitor Activates the WAF1/Cip1 Gene Promoter through the Sp1 Sites ☆

    Yoshihiro Sowa;Tetsuro Orita;Sachie Minamikawa;Katsunori Nakano

  • Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

    Susumu Nakata;Tatsushi Yoshida;Mano Horinaka;Mano Horinaka;Takumi Shiraishi

  • Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.

    Lili Huang;Yoshihiro Sowa;Toshiyuki Sakai;Arthur B Pardee

  • Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene

    Toshiyuki Sakai;Naoko Ohtani;Naoko Ohtani;Terri L. McGee;Paul D. Robbins

  • Hes1 Directly Controls Cell Proliferation through the Transcriptional Repression of p27Kip1

    Kaoru Murata;Masakazu Hattori;Norihito Hirai;Yoriko Shinozuka

  • ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle

    Masamitsu Yamamoto;Nobuyuki Marui;Toshiyuki Sakai;Narito Morii

  • Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo.

    Takayuki Yamaguchi;Reina Kakefuda;Nobuyuki Tajima;Yoshihiro Sowa

  • Flavonoids inhibit the expression of heat shock proteins

    Nobuko Hosokawa;Kazunori Hirayoshi;Akira Nakai;Ydhei Hosokawa

  • Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein.

    Tatsushi Yoshida;Takumi Shiraishi;Susumu Nakata;Mano Horinaka

  • Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells.

    Mano Horinaka;Tatsushi Yoshida;Takumi Shiraishi;Susumu Nakata

  • Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1.

    Swadesh K. Das;Takashi Hashimoto;Kazuo Shimizu;Tatsushi Yoshida

  • Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27.

    Christian Fischer;Hugo Sanchez-Ruderisch;Martina Welzel;Bertram Wiedenmann

  • Sp1 and NF-Y Synergistically Mediate the Effect of Vitamin D3 in the p27Kip1 Gene Promoter That Lacks Vitamin D Response Elements

    Toshiaki Inoue;Jun Kamiyama;Toshiyuki Sakai

Frequent Co-Authors

Hoyoku Nishino
Hoyoku Nishino Kyoto Prefectural University of Medicine
Keiji Wakabayashi
Keiji Wakabayashi University of Shizuoka
Masato Kasuga
Masato Kasuga National Center For Global Health and Medicine
Motomasa Kobayashi
Motomasa Kobayashi Osaka University
Thaddeus P. Dryja
Thaddeus P. Dryja Massachusetts Eye and Ear Infirmary
Masami Ishibashi
Masami Ishibashi Chiba University
Shunji Aoki
Shunji Aoki Hyogo University of Health Sciences
Paul D. Robbins
Paul D. Robbins University of Minnesota
Junichiro Yamaguchi
Junichiro Yamaguchi Waseda University
Takayoshi Suzuki
Takayoshi Suzuki Osaka University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Toshiyuki Sakai

Trending Scientists